4BIO Capital Portfolio Company Carisma Therapeutics and Sesen Bio Announce Merger Agreement

SparingVision Raises €75 Million Series B

4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A

Ray Therapeutics Receives $4M in Funding from the California Institute for Regenerative Medicine

Code Biotherapeutics Announces Collaboration with Takeda

4BIO Capital Portfolio Company Carisma to Collaborate with Moderna